Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
Clinical trial NCT04184115 · COMPLETED
Trial details
- NCT number
- NCT04184115
- Sponsor
- Repurposed Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-09
- Primary completion
- 2019-06-11
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.